Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis

Archives of Dermatology

Volumn 132, Issue 2, 1996, Pages 184-187

  Zonneveld, Ingrid M ^a   Bakker, Wiepke K ^b   Dijkstra, Piet F ^a   Bos, Jan D ^a   Van Soesbergen, Renée M ^b   Dinant, Huib J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ETIDRONIC ACID TC 99M; FOLIC ACID ANTAGONIST; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; BONE DISEASE; BONE PAIN; BONE RADIOGRAPHY; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DISTAL TIBIA FRACTURE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DISEASES, METABOLIC; FEMALE; FRACTURES, STRESS; HUMANS; MAGNETIC RESONANCE IMAGING; METHOTREXATE; MIDDLE AGED; OSTEOPOROSIS; PSORIASIS;

EID: 0030043506     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.2.184     Document Type: Article

References (15)

1. Weinstein GD, Frost P. Methotrexate for psoriasis: a new therapeutic schedule. Arch Dermatol. 1971;103:33-38.
2. van Dooren-Greebe RJ, Kuijpers ALA, Mulder J, de Boo Th, van de Kerkhof PCM. Methotrexate revisited: effects of long-term treatment in psoriasis. Br J Dermatol. 1994,130:204-210
3. Kremer JM, Lee JK. Safety and efficacy of methotrexate in treatment of arthritis. Arthritis Rheum. 1986;29.822-831.
4. Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. N Engl J Med 1994;330:1368-1375.
5. Nesbit M, Krivit W, Heyn R, Sharp H. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems Cancer 1976;37:1048-1054.
6. Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 1970;25:580-585.
7. Schwartz AM, Leonidas JC. Methotrexate osteopathy. Skeletal Radiol. 1984; 11:13-16
8. Preston SJ, Diamond T, Scott A, Laurent MR. Methotrexate osteopathy in rheumatic disease. Ann Rheum Dis 1993;52:582-585.
9. Gnudi S, Butturini L, Ripamonti C, Avella M, Bacci G The effect of methotrexate on bone Ital J Orthop Traumatol. 1988;14:227-231.
10. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone. J Bone Joint Surg Am. 1984;66:602-607.
11. Nevinny HB, Krant MJ, Moore EW Metabolic studies of the effects of methotrexate. Metabolism 1965;14:135-139.
12. Kate JN, Leboff MS, Wade JP, Brown EM, Liang MH. Effect of methotrexate on bone density and calcium homeostasis in rheumatoid arthritis. Clin Res. 1989:37 509. Abstract.
13. May KP, West SG, McDermott MT, Huffer WE The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats Arthritis Rheum 1994,37 201-206.
14. Stewart PJ, Green OC, Stern PH Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro. J Bone Miner Res. 1986;1:285-291.
15. Hanley DA, Ayer LM, Gundberg CM, Minuk GY Parameters of calcium metabolism during a pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis. Clin Invest Med. 1991, 14 282-287